Marshall Wace
GWPH

Marshall Wace’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Marshall Wace’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-85,060
Closed -$18.4M – 3509
2021
Q1 		$18.4M Buy
+85,060
New +$16M 0.08% 242
2020
Q3 		– Sell
-23,833
Closed -$2.92M – 2068
2020
Q2 		$2.92M Buy
23,833
+18,620
+357% +$2.11M 0.02% 646
2020
Q1 		$457K Buy
5,213
+2,258
+76% +$239K ﹤0.01% 996
2019
Q4 		$309K Sell
2,955
-45,672
-94% -$5.12M ﹤0.01% 1271
2019
Q3 		$5.59M Buy
48,627
+41,908
+624% +$6.36M 0.04% 474
2019
Q2 		$1.16M Sell
6,719
-5,147
-43% -$890K 0.01% 894
2019
Q1 		$2M Buy
11,866
+7,568
+176% +$1.13M 0.02% 738
2018
Q4 		$419K Buy
+4,298
New +$564K ﹤0.01% 1164
2016
Q1 		– Sell
-8,087
Closed -$562K – 1248
2015
Q4 		$562K Buy
+8,087
New +$659K 0.01% 791

Other funds holding GWPH

HDIM
Hanson & Doremus Investment Management Burlington, Vermont $869M AUM 23.62% 1-Year Est. Return

Marshall Wace's GWPH Position: Q2 2021 in Review

Marshall Wace sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2021, closing a stake of 85,060 shares — an estimated $18.4M sold.

Marshall Wace first reported a position in GWPH in Q4 2015 and held it in 9 quarters. The position peaked at $18.4M in Q1 2021. 1 fund tracked by Wall St. Rank holds GWPH as of Q2 2021.

  • Marshall Wace reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2021 after selling out during the quarter.
  • Marshall Wace sold 85,060 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2021, an estimated $18.4M.
  • Marshall Wace first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2015 and held it in 9 quarters.
  • Marshall Wace's GW Pharmaceuticals Plc American Depositary Shares position peaked at $18.4M in Q1 2021.
  • 1 fund tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2021.

Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.